"The ATIII LLC decided to discontinue development of this indication based on the level of additional data that would have been required to address the clinical development issues raised during the meeting with the FDA..."
What exactly were "the clinical development issues raised during the meeting with the FDA?"
Market Data 
Markets 
AI
